Biomea Fusion announced a clinical hold by the U.S. FDA on its diabetes drug trial due to potential toxic liver disease, causing a 60% drop in its shares.
Health care professionals welcome the FTC's new rule banning noncompete agreements but are concerned it may not protect those in nonprofit health care settings, potentially impacting most of the nation's medical professionals.
KFF Health News
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
“Overall, TS was found to double the screening compliance rates in certain populations, particularly in underserved areas where access to ophthalmic care is limited.”
A study found that patients with proliferative diabetic retinopathy treated with PRP monotherapy had higher rates of complications compared to those treated with anti-VEGF therapy.
The Congressional Budget Office projects a rise in the uninsured rate to 8.9% by 2034, driven by immigration and policy changes affecting young adults, despite a record low of 7.2% in 2023.